CN Patent

CN115611883B — 一种双环结构的PI3Kα抑制剂及其制备方法和用途

Assigned to Bioisland Laboratory · Expires 2025-03-28 · 1y expired

What this patent protects

本发明公开了一种如式(I)所示的化合物、其消旋体、立体异构体、氮氧化物、同位素替代物、药学上可接受的盐或溶剂合物： 本发明化合物在抑制ΡΙ3Kα/β/γ/δ激酶活性方面具有更优良的活性和选择性，并对ΡΙ3Kα突变型癌症细胞T‑47D和BT‑474的增殖具有优良的抑制活性。

USPTO Abstract

本发明公开了一种如式(I)所示的化合物、其消旋体、立体异构体、氮氧化物、同位素替代物、药学上可接受的盐或溶剂合物： 本发明化合物在抑制ΡΙ3Kα/β/γ/δ激酶活性方面具有更优良的活性和选择性，并对ΡΙ3Kα突变型癌症细胞T‑47D和BT‑474的增殖具有优良的抑制活性。

Drugs covered by this patent

Patent Metadata

Patent number
CN115611883B
Jurisdiction
CN
Classification
—
Expires
2025-03-28
Drug substance claim
No
Drug product claim
No
Assignee
Bioisland Laboratory
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.